Advertisement

The Journal of Microbiology

, Volume 50, Issue 1, pp 137–142 | Cite as

Effect of Lactobacillus reuteri on the proliferation of Propionibacterium acnes and Staphylococcus epidermidis

  • Mi-Sun Kang
  • Jong-Suk Oh
  • Seok-Woo Lee
  • Hoi-Soon Lim
  • Nam-Ki Choi
  • Seon-Mi Kim
Articles

Abstract

While it is generally accepted that Propionibacterium acnes is involved in the development of acne, other bacteria including Staphylococcus epidermidis have also been isolated from the acne lesion. The interaction between Lactobacillus reuteri, a probiotic bacterium, and acnegenic bacteria is unclear. This study examined the effects of L. reuteri on the proliferation of P. acnes and S. epidermidis. Human-derived L. reuteri strains (KCTC 3594 and KCTC 3678) and rat-derived L. reuteri KCTC 3679 were used. All strains exhibited significant inhibitory effects on the growth of P. acnes and S. epidermidis. The proliferation of P. acnes was decreased by 2-log scales after incubation with L. reuteri for 24 h. In addition, the proliferation of S. epidermidis was decreased by 3-log scales after incubation with L. reuteri for 24 h, whereas the growth of L. reuteri was unaffected by P. acnes or S. epidermidis. Among the L. reuteri strains examined, L. reuteri KCTC 3679 had the strongest inhibitory effect on the growth of P. acnes and S. epidermidis, followed by L. reuteri KCTC 3594 and L. reuteri KCTC 3678. Interestingly, reuterin, an antimicrobial factor, was produced only by L. reuteri KCTC 3594. The most pronounced the antibacterial activities of L. reuteri were attributed to the production of organic acids. Overall, these results suggest that L. reuteri may be a useful probiotic agent to control the growth of bacteria involved in acne inflammation and prevent acne.

Keywords

Lactobacillus reuteri Propionibacterium acnes Staphylococcus epidermidis antibacterial 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abad, C.L. and Safdar, N. 2009. The role of lactobacillus probiotics in the treatment or prevention of urogenital infections - a systematic review. J. Chemother. 21, 243–252.PubMedGoogle Scholar
  2. Ahola, A.J., Yli-Knuuttila, H., Suomalainen, T., Poussa, T., Ahlström, A., Meurman, J.H., and Korpela, R. 2002. Short-term consumption of probiotic-containing cheese and its effect on dental caries risk factors. Arch. Oral Biol. 47, 799–804.PubMedCrossRefGoogle Scholar
  3. Ahrné, S., Nobaek, S., Jeppsson, B., Adlerberth, I., Wold, A.E., and Molin, G. 1998. The normal Lactobacillus flora of healthy human rectal and oral mucosa. J. Appl. Microbiol. 85, 88–94.PubMedCrossRefGoogle Scholar
  4. Bettley, F.R. and Dale, T.L. 1976. The local treatment of acne. Br. J. Clin. Pract. 30, 67–69.PubMedGoogle Scholar
  5. Breathnach, A.S., Nazzaro-Porro, M., and Passi, S. 1984. Azelaic acid. Br. J. Dermatol. 111, 115–120.PubMedCrossRefGoogle Scholar
  6. Burkhart, C.G., Burkhart, C.N., and Lehmann, P.F. 1999. Acne: a review of immunologic and microbiologic factors. Postgrad. Med. J. 75, 328–331.PubMedGoogle Scholar
  7. Çaglar, E., Cildir, S.K., Ergeneli, S., Sandalli, N., and Twetman, S. 2006. Salivary mutans streptococci and lactobacilli levels after ingestion of the probiotic bacterium Lactobacillus reuteri ATCC 55730 by straws or tablets. Acta Odontol. Scand. 64, 314–318.PubMedCrossRefGoogle Scholar
  8. Cleusix, V., Lacroix, C., Vollenweider, S., Duboux, M., and Le Blay, G. 2007. Inhibitory activity spectrum of reuterin produced by Lactobacillus reuteri against intestinal bacteria. BMC Microbiol. 7, 101.PubMedCrossRefGoogle Scholar
  9. Cogen, A.L., Nizet, V., and Gallo, R.L. 2008. Skin microbiota: a source of disease or defence? Br. J. Dermatol. 158, 442–455.PubMedCrossRefGoogle Scholar
  10. El-Ziney, M.G., van den Tempel, T., Debevere, J., and Jakobsen, M. 1999. Application of reuterin produced by Lactobacillus reuteri 12002 for meat decontamination and preservation. J. Food Prot. 62, 257–261.PubMedGoogle Scholar
  11. Eschenbach, D.A., Davick, P.R., Williams, B.L., Klebanoff, S.J., Young-Smith, K., Critchlow, C.M., and Holmes, K.K. 1989. Prevalence of hydrogen peroxide-producing Lactobacillus species in normal women and women with bacterial vaginosis. J. Clin. Microbiol. 27, 251–256.PubMedGoogle Scholar
  12. Gill, H.S., Shu, Q., Lin, H., Rutherfurd, K.J., and Cross, M.L. 2001. Protection against translocating Salmonella typhimurium infection in mice by feeding the immuno-enhancing probiotic Lactobacillus rhamnosus strain HN001. Med. Microbiol. Immunol. 190, 97–104.PubMedGoogle Scholar
  13. Guarner, F., Perdigon, G., Corthier, G., Salminen, S., Koletzko, B., and Morelli, L. 2005. Should yoghurt cultures be considered probiotic? Br. J. Nutr. 93, 783–786.PubMedCrossRefGoogle Scholar
  14. Guin, J.D., Huber, D.S., and Gielerak, P.L. 1979. Antibiotic sensitivity of comedonal Propionibacterium acnes. Acta Derm. Venereol. 59, 552–554.PubMedGoogle Scholar
  15. Holland, K.T., Cunliffe, W.J., and Eady, E.A. 1979. Intergeneric and intrageneric inhibition between strains of Propionibacterium acnes and micrococcaceae, particularly Staphylococcus epidermidis, isolated from normal skin and acne lesions. J. Med. Microbiol. 12, 71–82.PubMedCrossRefGoogle Scholar
  16. Ishihara, K., Miyakawa, H., Hasegawa, A., Takazoe, I., and Kawai, Y. 1985. Growth inhibition of Streptococcus mutans by cellular extracts of human intestinal lactic acid bacteria. Infect. Immun. 49, 692–694.PubMedGoogle Scholar
  17. Johnson, M.L., Johnson, K.G., and Engel, A. 1984. Prevalence, morbidity, and cost of dermatological diseases. J. Am. Acad. Dermatol. 11, 930–936.PubMedCrossRefGoogle Scholar
  18. Kang, M.S., Oh, J.S., Lee, H.C., Lim, H.S., Lee, S.W., Yang, K.H., Choi, N.K., and Kim, S.M. 2011. Inhibitory effect of Lactobacillus reuteri on periodontopathic and cariogenic bacteria. J. Microbiol. 49, 193–199.PubMedCrossRefGoogle Scholar
  19. Kang, B.S., Seo, J.G., Lee, G.S., Kim, J.H., Kim, S.Y., Han, Y.W., Kang, H., Kim, H.O., Rhee, J.H., Chung, M.J., and et al. 2009. Antimicrobial activity of enterocins from Enterococcus faecalis SL-5 against Propionibacterium acnes, the causative agent in acne vulgaris, and its therapeutic effect. J. Microbiol. 47, 101–109.PubMedCrossRefGoogle Scholar
  20. Koreck, A., Pivarcsi, A., Dobozy, A., and Kemény, L. 2003. The role of innate immunity in the pathogenesis of acne. Dermatology 206, 96–105.PubMedCrossRefGoogle Scholar
  21. Leyden, J.J. 1997. Therapy for acne vulgaris. N. Engl. J. Med. 336, 1156–1162.PubMedCrossRefGoogle Scholar
  22. Leyden, J.J., Del Rosso, J.Q., and Webster, G.F. 2007. Clinical considerations in the treatment of acne vulgaris and other inflammatory skin disorders: focus on antibiotic resistance. Cutis 79, 9–25.PubMedGoogle Scholar
  23. Lüthi-Peng, Q., Schärer, S., and Puhan, Z. 2002. Production and stability of 3-hydroxypropionaldehyde in Lactobacillus reuteri. Appl. Microbiol. Biotechnol. 60, 73–80.PubMedCrossRefGoogle Scholar
  24. Meisler, D.M. and Mandelbaum, S. 1989. Propionibacterium-associated endophthalmitis after extracapsular cataract extraction. Review of reported cases. Ophthalmology 96, 54–61.Google Scholar
  25. Nam, C., Kim, S., Sim, Y., and Chang, I. 2003. Anti-acne effects of Oriental herb extracts: a novel screening method to select antiacne agents. Skin Pharmacol. Appl. Skin Physiol. 16, 84–90.PubMedCrossRefGoogle Scholar
  26. Nikawa, H., Makihira, S., Fukushima, H., Nishimura, H., Ozaki, Y., and Ishida, K. 2004. Lactobacillus reuteri in bovine milk fermented decreases the oral carriage of mutans streptococci. Int. J. Food Microbiol. 95, 219–223.PubMedCrossRefGoogle Scholar
  27. Niyomkam, P., Kaewbumrung, S., Kaewnpparat, S., and Panichayupakaranant, P. 2010. Antibacterial activity of Thai herbal extracts on acne involved microorganism. Pharm. Biol. 48, 375–380.PubMedCrossRefGoogle Scholar
  28. Ochsendorf, F. 2006. Systemic antibiotic therapy of acne vulgaris. J. Dtsch. Dermatol. Ges. 4, 828–841.PubMedCrossRefGoogle Scholar
  29. Patel, M., Bowe, W.P., Heughebaert, C., and Shalita, A.R. 2010. The development of antimicrobial resistance due to the antibiotic treatment of acne vulgaris: a review. J. Drugs Dermatol. 9, 655–664.PubMedGoogle Scholar
  30. Reid, G., Burton, J., and Devillard, E. 2004. The rationale for probiotics in female urogenital healthcare. Med. Gen. Med. 6, 49.Google Scholar
  31. Saavedra, J. 2000. Probiotics and infectious diarrhea. Am. J. Gastroenterol. 95, 16–18.CrossRefGoogle Scholar
  32. Shornikova, A.V., Casas, I.A., Mykkänen, H., Salo, E., and Vesikari, T. 1997. Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis. Pediatr. Infect. Dis. J. 16, 1103–1107.PubMedCrossRefGoogle Scholar
  33. Slininger, P.J., Bothast, R.J., and Smiley, K.L. 1983. Production of 3-hydroxypropionaldehyde from glycerol. Appl. Environ. Microbiol. 46, 62–67.PubMedGoogle Scholar
  34. Spinler, J.K., Taweechotipatr, M., Rognerud, C.L., Ou, C.N., Tumwasorn, S., and Versalovic, J. 2008. Human-derived probiotic Lactobacillus reuteri demonstrate antimicrobial activities targeting diverse enteric bacterial pathogens. Anaerobe 14, 166–171.PubMedCrossRefGoogle Scholar
  35. Szajewska, H. and Mrukowicz, J.Z. 2005. Use of probiotics in children with acute diarrhea. Paediatr. Drugs 7, 111–122.PubMedCrossRefGoogle Scholar
  36. Talarico, T.L., Casas, I.A., Chung, T.C., and Dobrogosz, W.J. 1988. Production and isolation of reuterin, a growth inhibitor produced by Lactobacillus reuteri. Antimicrob. Agents Chemother. 32, 1854–1858.PubMedGoogle Scholar
  37. Taniguchi, M., Nakazawa, H., Takeda, O., Kaneko, T., Hoshino, K., and Tanaka, T. 1998. Production of a mixture of antimicrobial organic acids from lactose by co-culture of Bifidobacterium longum and Propionibacterium freudenreichii. Biosci. Biotechnol. Biochem. 62, 1522–1527.PubMedCrossRefGoogle Scholar
  38. Webster, G.F., Leyden, J.J., Tsai, C.C., Baehni, P., and McArthur, W.P. 1980. Polymorphonuclear leukocyte lysosomal release in response to Propionibacterium acnes in vitro and its enhancement by sera from inflammatory acne patients. J. Invest. Dermatol. 74, 398–401.PubMedCrossRefGoogle Scholar
  39. Zouboulis, C.C. and Piquero-Martin, J. 2003. Update and future of systemic acne treatment. Dermatology 206, 37–53.PubMedCrossRefGoogle Scholar

Copyright information

© The Microbiological Society of Korea and Springer-Verlag Berlin Heidelberg 2012

Authors and Affiliations

  • Mi-Sun Kang
    • 1
  • Jong-Suk Oh
    • 1
  • Seok-Woo Lee
    • 2
    • 3
  • Hoi-Soon Lim
    • 3
  • Nam-Ki Choi
    • 2
    • 4
  • Seon-Mi Kim
    • 2
    • 4
  1. 1.Department of Microbiology, School of MedicineChonnam National UniversityGwangjuRepublic of Korea
  2. 2.Dental Science Research InstituteChonnam National UniversityGwangjuRepublic of Korea
  3. 3.Department of Dental EducationChonnam National UniversityGwangjuRepublic of Korea
  4. 4.Department of Pediatric DentistryChonnam National UniversityGwangjuRepublic of Korea

Personalised recommendations